- Home
- DSP vs RNAC Comparison
DSP vs RNAC Comparison
Compare DSP & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DSP | RNAC |
|---|---|---|
| Founded | 1999 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.3M | 214.8M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | DSP | RNAC |
|---|---|---|
| Price | $12.41 | $7.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 6 |
| Target Price | $18.11 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 188.5K | 183.9K |
| Earning Date | 06-16-2026 | 06-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 157.14 | N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $344,201,000.00 | $2,797,000.00 |
| Revenue This Year | $16.52 | N/A |
| Revenue Next Year | $16.62 | $26.02 |
| P/E Ratio | $35.00 | ★ N/A |
| Revenue Growth | ★ 19.00 | N/A |
| 52 Week Low | $8.11 | $5.98 |
| 52 Week High | $16.25 | $16.79 |
Technical Indicators
Market Signals| Indicator | DSP | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 68.06 | 49.06 |
| Support Level | $12.32 | $6.44 |
| Resistance Level | $13.20 | $8.10 |
| Average True Range (ATR) | 0.79 | 0.87 |
| MACD | 0.37 | 0.04 |
| Stochastic Oscillator | 85.08 | 31.73 |
Price Performance
Historical ComparisonAbout DSP Viant Technology Inc.
Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.